FDAnews
www.fdanews.com/articles/196900-astrazeneca-to-manufacture-oxford-universitys-covid-19-vaccine
AstraZeneca

AstraZeneca to Manufacture Oxford University’s COVID-19 Vaccine

May 1, 2020

AstraZeneca has entered into an agreement with Oxford University to develop and distribute Oxford’s COVID-19 vaccine.

If clinical trials show that the vaccine is effective, AstraZeneca will lead the development, worldwide manufacturing and distribution of the vaccine.

The vaccine candidate entered phase 1 trials last week in healthy volunteers aged 18 to 55 across five centers in southern England.

View today's stories